Literature DB >> 23197111

The resolution of inflammation.

Christopher D Buckley1, Derek W Gilroy, Charles N Serhan, Brigitta Stockinger, Paul P Tak.   

Abstract

In 2012, Nature Reviews Immunology organized a conference that brought together scientists and clinicians from both academia and industry to discuss one of the most pressing questions in medicine--how do we turn off rampant, undesirable inflammation? There is a growing appreciation that, similarly to the initiation of inflammation, the resolution of inflammation is an intricate and active process. Can we therefore harness the mediators involved in resolution responses to treat patients with chronic inflammatory or autoimmune diseases? Here, we ask five of the speakers from the conference to share their thoughts on this emerging field.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23197111     DOI： 10.1038/nri3362

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


  58 in total

Review 1.  Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation.

Authors:  C D Buckley; D Pilling; J M Lord; A N Akbar; D Scheel-Toellner; M Salmon
Journal:  Trends Immunol       Date:  2001-04       Impact factor: 16.687

Review 2.  Inflammatory resolution: new opportunities for drug discovery.

Authors:  Derek W Gilroy; Toby Lawrence; Mauro Perretti; Adriano G Rossi
Journal:  Nat Rev Drug Discov       Date:  2004-05       Impact factor: 84.694

3.  Resolution of inflammation by N-arachidonoylglycine.

Authors:  Sumner H Burstein; Catherine A McQuain; Alonzo H Ross; Rebecca A Salmonsen; Robert E Zurier
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

4.  Possible new role for NF-kappaB in the resolution of inflammation.

Authors:  T Lawrence; D W Gilroy; P R Colville-Nash; D A Willoughby
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

5.  Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria.

Authors:  Melanie J Stables; Justine Newson; Samir S Ayoub; Jeremy Brown; Catherine J Hyams; Derek W Gilroy
Journal:  Blood       Date:  2010-07-06       Impact factor: 22.113

6.  Chemiluminescent assay of alkaline phosphatase in human gingival crevicular fluid: investigations with an experimental gingivitis model and studies on the source of the enzyme within crevicular fluid.

Authors:  I L Chapple; S S Socransky; S Dibart; H D Glenwright; J B Matthews
Journal:  J Clin Periodontol       Date:  1996-06       Impact factor: 8.728

7.  Transcriptomic analyses of murine resolution-phase macrophages.

Authors:  Melanie J Stables; Sonia Shah; Evelyn B Camon; Ruth C Lovering; Justine Newson; Jonas Bystrom; Stuart Farrow; Derek W Gilroy
Journal:  Blood       Date:  2011-10-19       Impact factor: 22.113

Review 8.  Tissue stroma as a regulator of leukocyte recruitment in inflammation.

Authors:  Helen M McGettrick; Lynn M Butler; Chris D Buckley; G Ed Rainger; Gerard B Nash
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

9.  Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.

Authors:  Arnaud Didierlaurent; John Goulding; Seema Patel; Robert Snelgrove; Lionel Low; Magali Bebien; Toby Lawrence; Leonie S van Rijt; Bart N Lambrecht; Jean-Claude Sirard; Tracy Hussell
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

10.  Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor.

Authors:  Mauro Perretti; Nan Chiang; Mylinh La; Iolanda M Fierro; Stefano Marullo; Stephen J Getting; Egle Solito; Charles N Serhan
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440
View more
  138 in total

1.  A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Authors:  Hiroaki Kaku; Kai Fan Cheng; Yousef Al-Abed; Thomas L Rothstein
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells.

Authors:  Maria R Fernando; Mark A Giembycz; Derek M McKay
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

Review 3.  Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease.

Authors:  Matthew Spite
Journal:  Proc Nutr Soc       Date:  2013-09-02       Impact factor: 6.297

Review 4.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 5.  Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

Authors:  Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-03

6.  Local apoptosis mediates clearance of macrophages from resolving inflammation in mice.

Authors:  Emmanuel L Gautier; Stoyan Ivanov; Philippe Lesnik; Gwendalyn J Randolph
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

7.  Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush.

Authors:  Enrico Gugliandolo; Ramona D'amico; Marika Cordaro; Roberta Fusco; Rosalba Siracusa; Rosalia Crupi; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  J Neuroinflammation       Date:  2018-09-14       Impact factor: 8.322

8.  MALDI FTICR IMS of Intact Proteins: Using Mass Accuracy to Link Protein Images with Proteomics Data.

Authors:  Jeffrey M Spraggins; David G Rizzo; Jessica L Moore; Kristie L Rose; Neal D Hammer; Eric P Skaar; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-23       Impact factor: 3.109

9.  Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits.

Authors:  Nan Chiang; Masakazu Shinohara; Jesmond Dalli; Valbona Mirakaj; Megumi Kibi; Augustine M K Choi; Charles N Serhan
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

10.  Effect of cefoperazone sulbactam sodium combined with meropenem on the immune function in the treatment of neonatal pneumonia caused by multidrug-resistant bacteria.

Authors:  Mingjing Lin; Shuxia Zhu; Haimei Weng; Yi Zhu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.